膳食固醇吸收的遗传变异性影响冠心病风险
研究发现ABCG5/8罕见编码变异携带者非高密度脂蛋白胆固醇和植物固醇水平升高,冠心病风险增加;预测非HDL胆固醇升高1 mmol/L的ABCG5/8变异遗传评分与冠心病风险增加两倍相关(OR=2.01,95%CI 1.75-2.31,P=9.8×10^-23),显著高于其他非HDL胆固醇变异评分的风险增加54%(OR=1.54,95%CI 1.49-1.59,P=1.1×10^-154),提示膳食胆固醇和植物固醇均直接促进动脉粥样硬化形成。
要点
- ABCG5/8罕见编码变异携带者植物固醇水平升高且冠心病风险增加。
- 预测非HDL胆固醇升高1 mmol/L的ABCG5/8变异评分与冠心病风险增加两倍相关。
- 膳食胆固醇和植物固醇均直接促进动脉粥样硬化形成。
核心结论
- 胆固醇吸收的遗传变异影响循环非HDL胆固醇水平和冠心病风险。
- 膳食胆固醇和植物固醇均直接促进动脉粥样硬化形成。
主要发现
- 鉴定出九个对非HDL胆固醇有实质影响的罕见ABCG5/8编码变异,携带者植物固醇水平升高且冠心病风险增加。
- 八个罕见ABCG5/8变异与胆结石相关,符合其对肝细胞ABCG5/8转运功能的影响。
- 预测非HDL胆固醇升高1 mmol/L的ABCG5/8变异遗传评分与冠心病风险增加两倍相关(OR=2.01,95%CI 1.75-2.31,P=9.8×10^-23)。
- 其他非HDL胆固醇变异评分预测相同非HDL胆固醇升高时,冠心病风险仅增加54%(OR=1.54,95%CI 1.49-1.59,P=1.1×10^-154),两组效应差异P=2.4×10^-4。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To explore whether variability in dietary cholesterol and phytosterol absorption impacts the risk of coronary artery disease (CAD) using as instruments sequence variants in the ABCG5/8 genes, key regulators of intestinal absorption of dietary sterols. METHODS AND RESULTS: We examined the effects of ABCG5/8 variants on non-high-density lipoprotein (non-HDL) cholesterol (N up to 610 532) and phytosterol levels (N = 3039) and the risk of CAD in Iceland, Denmark, and the UK Biobank (105 490 cases and 844 025 controls). We used genetic scores for non-HDL cholesterol to determine whether ABCG5/8 variants confer greater risk of CAD than predicted by their effect on non-HDL cholesterol. We identified nine rare ABCG5/8 coding variants with substantial impact on non-HDL cholesterol. Carriers have elevated phytosterol levels and are at increased risk of CAD. Consistent with impact on ABCG5/8 transporter function in hepatocytes, eight rare ABCG5/8 variants associate with gallstones. A genetic score of ABCG5/8 variants predicting 1 mmol/L increase in non-HDL cholesterol associates with two-fold increase in CAD risk [odds ratio (OR) = 2.01, 95% confidence interval (CI) 1.75-2.31, P = 9.8 × 10-23] compared with a 54% increase in CAD risk (OR = 1.54, 95% CI 1.49-1.59, P = 1.1 × 10-154) associated with a score of other non-HDL cholesterol variants predicting the same increase in non-HDL cholesterol (P for difference in effects = 2.4 × 10-4). CONCLUSIONS: Genetic variation in cholesterol absorption affects levels of circulating non-HDL cholesterol and risk of CAD. Our results indicate that both dietary cholesterol and phytosterols contribute directly to atherogenesis.
引用
- Helgadottir A, Thorleifsson G, Alexandersson KF, et al. Genetic variability in the absorption of dietary sterols affects the risk of coronary artery disease. Eur Heart J. 2020. PMID: 32702746. doi:10.1093/eurheartj/ehaa531
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。